9999999995-21-002358.txt : 20210616 9999999995-21-002358.hdr.sgml : 20210616 20210616001511 ACCESSION NUMBER: 9999999995-21-002358 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210615 DATE AS OF CHANGE: 20210616 EFFECTIVENESS DATE: 20210615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-257032 FILM NUMBER: 211020395 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2021-06-15 17:00:00
S-1
0001750149 Inhibikase Therapeutics, Inc. 333-257032